Drug
Clevidipine clinical trials
Also written Cleviprex.
- studies test it
- 28
- open now
- 3
- in phase 3
- 14
- first study started
- 2003
Keep track of what changes. Save the clevidipine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Studies by the year they started
28 studies that test it; most in 2004 (4)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 4 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 14
- Phase 4
- 8
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 14
The Medicines Company (10) · Henry Ford Health System (2) · ProMedica Health System (1) · University of California, San Francisco (1) · Nationwide Children's Hospital (1) · NYU Langone Health (1) · North Texas Veterans Healthcare System (1) · University of California, San Diego (1)
Often tested with
Tested in the same studies.
Phenylephrine (1) · Dexmedetomidine (1) · Calcium Chloride (1) · Total Parenteral Nutrition (1) · Propofol (1)
Studies
Open first, then newest update. How each study uses clevidipine is read from its arms, and is right about nine times in ten.
Testing it · 28
- Effect of Treatment of Pre-induction Hypertension on Hemodynamic Stability During Induction of General AnesthesiaNot yet recruitingPhase 4University of California, San DiegoNCT06063772Written as Clevidipine
- a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergencyNot yet recruitingPhase 3Qilu Pharmaceutical (Hainan) Co., Ltd.NCT05922436Written as QLG2071
- A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergencyNot yet recruitingPhase 3CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT05783557Written as Clevidipine Butyrate Injectable Emulsion
- Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER)TerminatedPhase 4Chiesi Farmaceutici S.p.A.NCT01938547Written as clevidipine
- Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic StrokeCompletedPhase 3ProMedica Health SystemNCT05175547Written as Clevidipine
- Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid HemorrhageTerminatedPhase 2Henry Ford Health SystemNCT00978822Written as Clevidipine butyrate injectable emulsion
- Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)WithdrawnPhase 2Henry Ford Health SystemNCT02011321Written as clevidipine
- Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot StudyCompletedEarly Phase 1University of California, San FranciscoNCT03719001Written as Clevidipine
- The Energy Dose StudyTerminatedPhase 2Emory UniversityNCT01369147Written as Clevidipine
- Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®)WithdrawnPhase 4University of ZurichNCT03300479Written as Clevidipine
- Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive EmergenciesStatus unknownPhase 3Nanjing Yoko Biomedical Co., Ltd.NCT04670809Written as Clevidipine Butyrate Injection
- Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHFWithdrawnPhase 3The Medicines CompanyNCT04592380Written as Stage 1: Clevidipine (double-blinded)
- The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive TherapyWithdrawnPhase 4Methodist HealthcareNCT01042574Written as Clevidipine butyrate
- The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured PatientsWithdrawnPhase 4Columbia UniversityNCT01526876Written as clevidipine butyrate
- An Open-label Trial of Clevidipine for Controlled Hypotension During Spinal FusionCompletedPhase 2/3Nationwide Children's HospitalNCT01645111Written as Clevidipine
- A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical PatientsCompletedPhase 4NYU Langone HealthNCT00952081Written as Clevidipine
- Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)CompletedPhase 2The Medicines CompanyNCT00799604Written as clevidipine
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)CompletedPhase 3The Medicines CompanyNCT00803634Written as Clevidipine
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)CompletedPhase 3The Medicines CompanyNCT00666328Written as clevidipine
- Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)CompletedPhase 3The Medicines CompanyNCT00093249Written as clevidipine
Codes
What other systems call clevidipine · ClinicalTrials.gg INT004145
- MeSH (NLM) C118563clevidipineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 19O2GP3B7QCLEVIDIPINEConfirmed FDA, NLM, Wikidata
- Wikidata Q5132338clevidipineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72727ClevidipineOne source FDA
- DrugBank DB04920One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C118563 | clevidipine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 19O2GP3B7Q | CLEVIDIPINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5132338 | clevidipine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72727 | Clevidipine | One source FDA |
| DrugBank | DB04920 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.